Home > Insider Trading > Filing (0000905718-21-001539)

Filing Details

Accession Number:: 0000905718-21-001539
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-26 13:15:44
Reporting Period:: 2021-11-23

Accepted Time:: 2021-11-26 13:15:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759655	Privia Health Group Inc.	PRVA	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1308574	M Alexander Knaster	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22 Floor New York NY 10065	No	No	Yes	No
1554913	Pamplona Capital Management, Llc	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22 Floor New York NY 10065	No	No	Yes	No
1554914	Pamplona Capital Partners Iii, L.p.	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22 Floor New York NY 10065	No	No	Yes	No
1554942	Pamplona Capital Management, Llp	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22 Floor New York NY 10065	No	No	Yes	No
1650903	Ltd Malta Investments Pe Pamplona	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22 Floor New York NY 10065	No	No	Yes	No
1844403	C. John Halsted	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1859731	Ltd Iii Advisors Equity Pamplona	C/O Pamplona Capital Management, Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-11-23	1,791,175	$27.70	20,019,808	No	4	S	Indirect	See Foonotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Foonotes

Footnotes

This statement is being filed by (i) Pamplona Capital Partners III, L.P., (ii) Pamplona Equity Advisors III Ltd, (iii) Pamplona PE Investments Malta Limited, (iv) Pamplona Capital Management LLP, (v) Pamplona Capital Management LLC, (vi) John C. Halsted, and (vii) Alexander Knaster (the foregoing, collectively, the "Reporting Persons").
Pursuant to an underwriting agreement, dated November 18, 2021 (the "Underwriting Agreement"), and in connection with the public offering of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the Company, the Company sold 6,000,000 shares (excluding 900,000 additional shares which the underwriters have the right to purchase) of Common Stock pursuant to the final prospectus filed by the Company on November 16, 2021, which offering was consummated on November 23, 2021 (the "Public Offering"). The amount above represents the $30.62 public maximum offering price per share of Common Stock in the Public Offering less the effective public offering discount and underwriting discount of $2.93 per share of Common Stock. The shares sold were held by a private investor group, which includes Pamplona Capital Partners III, L.P.
As of November 23, 2021, as a result of the Public Offering, the Reporting Persons may be deemed to beneficially own indirectly 20,019,808 shares of Common Stock by reason of the shares in the Company held by Pamplona Capital Partners III, L.P. Pamplona Capital Partners III, L.P. is controlled by Pamplona Equity Advisors III Ltd, its general partner. John C. Halsted owns 100% of the shares of Pamplona Equity Advisors III, Ltd. Pamplona PE Investments Malta Limited serves as an investment manager to Pamplona Capital Partners III, L.P. Pamplona Capital Management LLP, and Pamplona Capital Management LLC (together, the "Pamplona Manager Entities") serve as investment advisors to Pamplona PE Investments Malta Limited. Mr. John C. Halsted and Mr. Alexander Knaster are the principals of the Pamplona Manager Entities.
Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.